Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Nov 22;327(7425):1209-13.
doi: 10.1136/bmj.327.7425.1209.

Recent developments in beta lactamases and extended spectrum beta lactamases

Joumana N Samaha-Kfoury  1 , George F Araj
Affiliations
Review

Recent developments in beta lactamases and extended spectrum beta lactamases

Joumana N Samaha-Kfoury et al. BMJ. .

Abstract

Resistance to β lactam antibiotics is an increasing problem worldwide. This review describes the classification and mechanism of action of β lactamases and the options available for detecting, treating, and controlling extended spectrum β lactamases

PubMed Disclaimer

Figures

Fig 1
Fig 1
Molecular structure of β lactamase. Adapted from http://biosafety.ihe.be/AR/betalactamase.html
Fig 2
Fig 2
Double disk approximation, or double disk synergy, test to detect ESBL producing bacteria
See this image and copyright information in PMC

References

    1. Kotra LP, Samama J, Mobashery S. Beta-lactamases and resistance to beta-lactam antibiotics. In: Lewis K, Salyers AA, Taber HW, Wax RG, eds. Bacterial resistance to antimicrobials. New York: Marcel Decker, 2002: 123-60.
    1. Araj GF, Kanj SA. Current status and changing trends of antimicrobial resistance in Lebanon. Leb Med J 2000;48: 221-6. - PubMed
    1. Stratton CW. Mechanisms of bacterial resistance to antimicrobial agents. Leb Med J 2000;48: 186-98. - PubMed
    1. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14: 933-51. - PMC - PubMed
    1. Dbaibo GS. Old and new targets of antibacterial therapy. Leb Med J 2000;48: 177-81. - PubMed